04:32 PM EDT, 06/20/2025 (MT Newswires) -- AIM ImmunoTech ( AIM ) said Friday it has received a notification from NYSE American stating that the company is not in compliance with the stock exchange's minimum stockholders' equity requirements.

NYSE American had issued a warning on Dec. 17, 2024, for the same reasons and has issued the latest letter because the deficiency remained as of March 31, the company said.

AIM also said that in February, NYSE American accepted a plan filed by the company to regain compliance by June 11, 2026.

The company said its shares restarted trading on NYSE American on June 17.

AIM shares were rising 3.2% in recent after-hours activity.